BioCentury
ARTICLE | Clinical News

Zeldox ziprasidone regulatory update

February 12, 2001 8:00 AM UTC

PFE's Zeldox serotonin and dopamine antagonist received FDA approval to treat schizophrenia. PFE said Zeldox's association with a small prolongation of the QTc interval on electrocardiograms (ECG) in ...